Sector News

DSM acquires animal health, nutrition businesses from Erber Group for more than $1 billion

June 16, 2020
Chemical Value Chain

DSM has reached an agreement to acquire the Biomin and Romer Labs businesses from Erber Group (Getzersdorf, Austria), an animal nutrition and health company, for an enterprise value of €980 million ($1.1 billion).

Erber Group’s Sanphar and EFB businesses, representing 7% of its total sales, are not included in this transaction and will “be carved out before closing,” DSM says. The deal is subject to customary conditions and expected to close in the fourth quarter of 2020.

The value of the transaction represents an EV/EBITDA multiple of about 14 times 2020 EBITDA, the company says. The acquisition will be debt financed, with committed bridge financing in place. DSM says it continues to benefit from a strong balance sheet and remains committed to maintaining a strong investment-grade credit profile.

The acquired businesses, Biomin and Romer Labs, specialize primarily in mycotoxin risk management, gut health performance management, and food and feed safety diagnostic solutions. They have combined annual sales of €330 million and an adjusted EBITDA margin above 20% for the 12 months ended March 2020, with a high single-digit organic sales growth rate over the past five years, DSM says.

DSM expects the acquisition to provide revenue-enhancing synergies. The earnings per share contribution of the acquisition in 2021 is expected to be €0.15, DSM says. “Biomin and Romer Labs will help strengthen and accelerate the growth of our specialty animal nutrition and health offering, including our big data and diagnostic capabilities, and it is exciting to be entrusted to take these family-founded businesses forward,” say Geraldine Matchett and Dimitri de Vreeze, co-CEOs at DSM.

Erich Erber, founder and president of Erber Group, says that under DSM, “Biomin and Romer Labs will be able to use their new scale to intensify our joint contribution to a more sustainable world’s food supply.”

DSM says that Biomin’s technology provides protection against mycotoxins that occur as a result of natural fungus contaminants in animal feed and threaten the health of animals and humans. It is also a producer of phytogenic and probiotic feed alternatives to antibiotics. Romer Labs offers diagnostic technology with testing solutions for the analysis of mycotoxins in feed and food, food allergens and pathogens, as well as veterinary drug residues, with accredited full-service labs in Austria, the UK, the US, and Singapore, DSM says.

By: Sotirios Frantzanas

Source: Chemical Week

Related News

October 24, 2020

Johnson Matthey completes new plant in China for fuel-cell components

Chemical Value Chain

Johnson Matthey is expanding its fuel cell operations into China with a £7.5-million facility to manufacture critical components for customers in the region.

October 24, 2020

Borealis commissions naphtha-storage cavern in Finland

Chemical Value Chain

Having invested around EUR 25 million in the construction of this 80,000-m3 facility, Borealis can now source and store naphtha for its Porvoo operations from the global market in a more flexible, cost-efficient, and secure way.

October 24, 2020

Mitsubishi Chemical names non-Japanese national as next CEO

Chemical Value Chain

Mitsubishi Chemical Holdings, Japan’s largest chemical maker, has named Jean-Marc Gilson, CEO of plant-ingredients maker Roquette Frères (Lestrem, France), as its next CEO, effective 1 April 2021.

Send this to a friend